Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: ethinyl estradiol; norethindrone

« Back to Dashboard

Ethinyl estradiol; norethindrone is the generic ingredient in eigthy-seven branded drugs marketed by Warner Chilcott Llc, Amneal Pharms, Barr, Famy Care Ltd, Warner Chilcott, Watson Labs, Ortho Mcneil Pharm, LPI, Ortho Mcneil Janssen, Janssen Pharms, Glenmark Generics, Vintage Pharms Llc, Novast Labs Ltd, Vintage Pharms, Lupin Ltd, Barr Labs Inc, and Parke Davis, and is included in ninety-five NDAs. There are four patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are twenty-six drug master file entries for ethinyl estradiol; norethindrone. Nine suppliers are listed for this compound.

Summary for Generic Name: ethinyl estradiol; norethindrone

Tradenames:87
Patents:4
Applicants:17
NDAs:95
Drug Master File Entries: see list26
Suppliers: see list9

Clinical Trials for: ethinyl estradiol; norethindrone

Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Fasting Conditions
Status: Completed Condition: Bioequivalence

Drug Interaction Study of Isavuconazole and Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone
Status: Completed Condition: Pharmacokinetics of Isavuconazole; Pharmacokinetics of Ethinyl Estradiol and Norethindrone; Healthy Volunteers

Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Non-Fasted Conditions
Status: Completed Condition: Healthy

Pharmacokinetics of NPC-01 After Single Oral Administration in Healthy Female Volunteers
Status: Completed Condition: Healthy

Drug Interaction Study of an OCP (Norethindrone (ND) Acetate and Ethinyl Estradiol (EE))With a Combination of Daclatasvir (DCV) Asunaprevir (ASV) and BMS-791325
Status: Completed Condition: Hepatitis C

A Pharmacokinetic Study of Colchicine With an Oral Contraceptive
Status: Completed Condition: Pharmacokinetics

Pharmacodynamics of NPC-01/IKH-01; Effect of NPC-01/IKH-01 on Sexual Hormone Concentrations in Healthy Female Volunteers
Status: Completed Condition: Healthy

Oral Contraceptive Ethinyl Estradiol Dose Effect on Postpartum Depression and Sexual Functioning Scales
Status: Recruiting Condition: Postpartum Depressive Mood; Postpartum Sexual Function

Effect of Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Norethindrone-Ethinyl Estradiol in Healthy Female Adult Volunteers
Status: Terminated Condition: Healthy

Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine (VIRAMUNE) and Ethinyl Estradiol/Norethindrone in HIV-1 Infected Women
Status: Completed Condition: HIV Infections

Study of Safety and Efficacy of an Oral Contraceptive
Status: Completed Condition: Prevention of Pregnancy

A Pharmacokinetics (PK) and Safety Study to Determine the Effect of Repeat Dosing of Trametinib on Combined Oral Contraceptive (Norethindrone Plus Ethinyl Estradiol) in Female Subjects With Solid Tumors
Status: Not yet recruiting Condition: Cancer

TMC278-TiDP6-C136: Effect of TMC278 on Ethinylestradiol and Norethindrone in Healthy Women.
Status: Completed Condition: HIV; AIDS; Oral Contraceptive

Clinical Study Investigating the Conversion of the Contraceptive Compound Norethisterone Within the Body Towards the Contraceptive Compound Ethinylestradiol
Status: Active, not recruiting Condition: Pharmacokinetics

An Evaluation of the Pharmacokinetics of an Oral Contraceptive (Brevicon) When Co-administered With Albiglutide .
Status: Completed Condition: Healthy Female Volunteers; Diabetes Mellitus, Type 2

A Study in Healthy Female Participants Investigating the Effect of TMC435 on the Pharmacokinetics of the Synthetic Hormones of the Oral Contraceptive Ovysmen
Status: Completed Condition: Hepatitis C Virus

Study of Safety and Efficacy of an Oral Contraceptive
Status: Completed Condition: Contraception

A Pharmacokinetics, Pharmacodynamics, and Safety Study of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol When Co-administered With GSK1322322 in Healthy Adult Women
Status: Not yet recruiting Condition: Infections, Bacterial

Study of Safety and Efficacy of an Oral Contraceptive
Status: Completed Condition: Contraception

Gender Disparity and Hormones in Cystic Fibrosis
Status: Recruiting Condition: Cystic Fibrosis (CF)

A Study of Tocilizumab in Combination With an Oral Contraceptive in Patients With Rheumatoid Arthritis
Status: Completed Condition: Rheumatoid Arthritis

Study of Bleeding With Extended Administration of an Oral Contraceptive
Status: Completed Condition: Contraception

Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Dysmenorrhea
Status: Completed Condition: Dysmenorrhea

Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Primary Dysmenorrhea
Status: Completed Condition: Dysmenorrhea

Efficacy and Safety,Long-term Study of Low-dose Oral Contraceptive Pill to Treat Dysmenorrhea.
Status: Completed Condition: Dysmenorrhea

Post Operative Continuous Active Combination Sex Steroids for the Prevention of Recurrent Endometrioma Formation
Status: Withdrawn Condition: Endometrioma

Evaluation of Physiologic and Standard Sex Steroid Replacement Regimens in Women With Premature Ovarian Failure
Status: Completed Condition: Premature Ovarian Failure

Efficacy and Safety Study of NPC-01 to Treat Dysmenorrhea
Status: Completed Condition: Dysmenorrhea

Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus
Status: Completed Condition: Systemic Lupus Erythematosus

Phase II Randomized Study of Leuprolide Vs Oral Contraceptive Therapy Vs Leuprolide and Oral Contraceptive Therapy for Ovarian Hyperandrogenism
Status: Completed Condition: Hyperandrogenism

M0001 Effects on Oral Contraceptive Plasma Levels
Status: Completed Condition: Healthy Volunteers

Evaluate the Effect of VI-0521 on the Pharmacokinetics of Oral Contraceptive in Healthy Female Subjects
Status: Completed Condition: Healthy

Efficacy and Safety, Long-Term Study of NPC-01 to Treat Dysmenorrhea Associated With Endometriosis
Status: Completed Condition: Dysmenorrhea

Study of the Contraceptive Efficacy and Safety of a NOMAC-E2 Combined Oral Contraceptive (COC)(P06448)
Status: Terminated Condition: Contraception

Treatment of Non-Gestational Acute Uterine Bleeding: A Randomized Trial
Status: Completed Condition: Uterine Hemorrhage; Menorrhagia

A Study to Evaluate the Effects of Different Methods of Birth Control on the Drug Actions of Zidovudine (an Anti-HIV Drug) in HIV-Positive Women and to Compare Zidovudine Metabolism in Men and Women
Status: Completed Condition: HIV Infections

To Compare SH T00658ID Over Ortho Tri-Cyclen Lo (US/Canada)
Status: Completed Condition: Contraception

A Study of Pharmacokinetic Drug Interaction Study of the Hedgehog Pathway Inhibitor GDC-0449 in Combination With Rosiglitazone or Combined Oral Contraceptive in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy Exists
Status: Completed Condition: Solid Cancers

Impact of Oral Contraceptives on GABA and Neurosteroids
Status: Terminated Condition: Healthy

Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women
Status: Completed Condition: HIV Infections; Pregnancy

Breastfeeding and Oral Contraceptives: a Randomized, Controlled Trial
Status: Completed Condition: Breast Feeding; Contraception

Oral Contraceptive (OC) Estrogen Dose and Breast Proliferation
Status: Recruiting Condition: Oral Contraceptive

Oral Contraceptive (OC) Progestin Dose and Breast Proliferation
Status: Completed Condition: Oral Contraceptive

Study of Loestrin 24(24 Days of "Real" Pills) Fe Versus Loestrin 1/20 (21 "Real" Pills)
Status: Completed Condition: Pelvic Pain; Headaches; Emotional

A Study of the Effects of GSK189075 on PK Profiles of an Oral Contraceptive Pill When Given to Healthy Female Volunteers
Status: Completed Condition: Type 2 Diabetes Mellitus; Diabetes Mellitus, Type 2

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
NORETHINDRONE AND ETHINYL ESTRADIOL
ethinyl estradiol; norethindrone
TABLET;ORAL-21070685Jan 29, 1987DISCNNo<disabled><disabled>
Janssen Pharms
ORTHO-NOVUM 7/7/7-21
ethinyl estradiol; norethindrone
TABLET;ORAL-21018985Apr 4, 1984DISCNNo<disabled><disabled>
Novast Labs Ltd
LARIN FE 1/20
ethinyl estradiol; norethindrone acetate
TABLET;ORAL-28091454Aug 26, 2013RXNo<disabled><disabled>
Warner Chilcott Llc
OVCON-35
ethinyl estradiol; norethindrone
TABLET;ORAL-28017716Approved Prior to Jan 1, 1982RXYes<disabled><disabled>
Vintage Pharms
GILDAGIA
ethinyl estradiol; norethindrone
TABLET;ORAL-28078376Nov 6, 2012RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc